Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

More articles from Metabolism, Transport, and Pharmacogenetics

  • Novel Bile Acid-Dependent Mechanisms of Hepatotoxicity Associated with Tyrosine Kinase Inhibitors
    You have access
    Novel Bile Acid-Dependent Mechanisms of Hepatotoxicity Associated with Tyrosine Kinase Inhibitors
    Chitra Saran, Louise Sundqvist, Henry Ho, Jonna Niskanen, Paavo Honkakoski and Kim L. R. Brouwer
    Journal of Pharmacology and Experimental Therapeutics February 2022, 380 (2) 114-125; DOI: https://doi.org/10.1124/jpet.121.000828
  • Central Nervous System Distribution of an Opioid Agonist Combination with Synergistic Activity
    You have access
    Central Nervous System Distribution of an Opioid Agonist Combination with Synergistic Activity
    Jessica I. Griffith, Minjee Kim, Daniel J. Bruce, Cristina D. Peterson, Kelley F. Kitto, Afroz S. Mohammad, Sneha Rathi, Carolyn A. Fairbanks, George L. Wilcox and William F. Elmquist
    Journal of Pharmacology and Experimental Therapeutics January 2022, 380 (1) 34-46; DOI: https://doi.org/10.1124/jpet.121.000821
  • Differential Susceptibilities of Catecholamines to Metabolism by Monoamine Oxidases
    You have access
    Differential Susceptibilities of Catecholamines to Metabolism by Monoamine Oxidases
    David S. Goldstein, Genessis Castillo, Patti Sullivan and Yehonatan Sharabi
    Journal of Pharmacology and Experimental Therapeutics November 2021, 379 (3) 253-259; DOI: https://doi.org/10.1124/jpet.121.000826
  • You have access
    Cationic Compounds with SARS-CoV-2 Antiviral Activity and Their Interaction with Organic Cation Transporter/Multidrug and Toxin Extruder Secretory Transporters
    Lucy Martinez-Guerrero, Xiaohong Zhang, Kimberley M. Zorn, Sean Ekins and Stephen H. Wright
    Journal of Pharmacology and Experimental Therapeutics October 2021, 379 (1) 96-107; DOI: https://doi.org/10.1124/jpet.121.000619
  • You have access
    Protein Kinase N Family Negatively Regulates Constitutive Androstane Receptor-Mediated Transcriptional Induction of Cytochrome P450 2b10 in the Livers of Mice
    Atsushi Kawase, Hideyuki Mukai, Shunsuke Tateishi, Shintaro Kuroda, Akira Kazaoka, Ryosuke Satoh, Hiroaki Shimada, Reiko Sugiura and Masahiro Iwaki
    Journal of Pharmacology and Experimental Therapeutics October 2021, 379 (1) 53-63; DOI: https://doi.org/10.1124/jpet.121.000790
  • You have access
    Enhancing Target Tissue Levels and Diminishing Plasma Clearance of Ionizing Zwitterionic Antidotes in Organophosphate Exposures
    Yan-Jye Shyong, Yadira Sepulveda, Arnold Garcia, Nathan M. Samskey, Zoran Radic, Rakesh K. Sit, K. Barry Sharpless, Jeremiah D. Momper and Palmer Taylor
    Journal of Pharmacology and Experimental Therapeutics September 2021, 378 (3) 315-321; DOI: https://doi.org/10.1124/jpet.121.000715
  • Open Access
    Evaluation of Ipatasertib Interactions with Itraconazole and Coproporphyrin I and III in a Single Drug Interaction Study in Healthy Subjects
    Rucha S. Sane, Kit Wun Kathy Cheung, Eunpi Cho, Bianca M. Liederer, Justin Hanover, Vikram Malhi, Emile Plise, Susan Wong and Luna Musib
    Journal of Pharmacology and Experimental Therapeutics August 2021, 378 (2) 87-95; DOI: https://doi.org/10.1124/jpet.121.000620
  • Open Access
    In Vitro Assessment of the Drug–Drug Interaction Potential of Verinurad and Its Metabolites as Substrates and Inhibitors of Metabolizing Enzymes and Drug Transporters
    V. Sashi Gopaul, Anna Vildhede, Tommy B. Andersson, Fredrik Erlandsson, Caroline A. Lee, Susanne Johansson and Constanze Hilgendorf
    Journal of Pharmacology and Experimental Therapeutics August 2021, 378 (2) 108-123; DOI: https://doi.org/10.1124/jpet.121.000549
  • <em>γ</em>-Hydroxybutyric Acid–Ethanol Drug-Drug Interaction: Reversal of Toxicity with Monocarboxylate Transporter 1 Inhibitors
    You have access
    γ-Hydroxybutyric Acid–Ethanol Drug-Drug Interaction: Reversal of Toxicity with Monocarboxylate Transporter 1 Inhibitors
    Vivian Rodriguez-Cruz and Marilyn E. Morris
    Journal of Pharmacology and Experimental Therapeutics July 2021, 378 (1) 42-50; DOI: https://doi.org/10.1124/jpet.121.000566
  • You have access
    Organic Anion–Transporting Polypeptide 1B1/1B3–Mediated Hepatic Uptake Determines the Pharmacokinetics of Large Lipophilic Acids: In Vitro–In Vivo Evaluation in Cynomolgus Monkey
    Heather Eng, Yi-an Bi, Mark A. West, Sangwoo Ryu, Emi Yamaguchi, Rachel E. Kosa, David A. Tess, David A. Griffith, John Litchfield, Amit S. Kalgutkar and Manthena V. S. Varma
    Journal of Pharmacology and Experimental Therapeutics April 2021, 377 (1) 169-180; DOI: https://doi.org/10.1124/jpet.120.000457

Pages

  • Next
  • 1
  • 2
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics